The data presented here indicate that PD-1 (PDCD1) and CTLA4, two biomarkers used to evaluate immune-checkpoint inhibitor efficacy ( Pardoll, 2012 ), showed a highly significant correlation with INMT expression in HNSC.
← all excerpts
Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
1
—
—